Creating a database for breast cancer patients
Creation of a Prospective and Retrospective Breast Cancer Database
This study is creating a detailed database of information from breast cancer patients to help improve treatment options for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Institut Claudius Regaud Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT02884284 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a comprehensive clinical, biological, and pathological database for breast cancer patients, primarily focusing on prospective data collection while also incorporating retrospective data. The database will facilitate easier access to clinical and biological information for the scientific community, thereby enhancing the optimization of treatment strategies for breast cancer. Data will be collected from patients treated at the Toulouse Centre, ensuring a structured approach to data management.
Who should consider this trial
Good fit: Ideal candidates for this project are female patients with histologically confirmed breast cancer of any stage who are affiliated with a social security system in France.
Not a fit: Patients with psychiatric or medical conditions that prevent them from providing informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this database could significantly improve the treatment and management of breast cancer by providing valuable insights and data to healthcare professionals.
How similar studies have performed: While this approach is essential for bridging research and clinical practice, similar database initiatives have shown promise in enhancing patient care and outcomes in other conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patient * Histologically confirmed breast cancer of any stage * Affiliated to a social security system in france * Who signed the informed consent Exclusion Criteria: * Any psychiatric or medical condition that would make the patient unable to give a signed informed consent
Where this trial is running
Toulouse
- Institut claudius regaud IUCT ONCOPOLE — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Florence DALENC, MD — Institut claudius regaud Toulouse ONCOPOLE
- Study coordinator: Florence DALENC, MD
- Email: dalenc.florence@iuct-oncopole.fr
- Phone: 5 31 15 51 22
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.